Equibles does not estimate personal net worth.
Get an email with a short summary when Ginkgo Bioworks Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get DNA alertsDaniel Waid Marshall has spoken on 5 earnings calls across 1 company, most recently for Ginkgo Bioworks Holdings, Inc. on November 5, 2026. Ginkgo Bioworks Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ginkgo Bioworks Holdings, Inc. includes Jason Kelly (CEO and Board Member), Steven Coen (CFO), Reshma Shetty (COO and Board Member) and 7 others.
“Manager of Communications and Ownership. I'm joined by Jason Kelly, our co-founder and CEO, and Steve Cohen, our CFO. Thanks, as always, for joining us. We're looking forward to updating you on our progress.”
“We're also going to provide insight into how we are going to scale the capabilities of Nebula, our autonomous lab in Boston, and share an update on how we are getting autonomous labs like Nebula into the hands of the next generation of scientists.”
“As usual, we'll end with a Q&A session, and I'll take questions from analysts, investors, and the public.”
“I'm joined by Jason Kelly, our co-founder and CEO, and our new CFO, Steve Cohen. Thanks, as always, for joining us. We're looking forward to updating you on our progress.”
“I've spent much of that time working behind the scenes with our investor relations team on these earnings calls, but I'm thrilled to be joining you for the first time live on air.”
Source not stated
Biotechnology · Healthcare
